Skip to main content
. 2019 Oct 6;10(23):5805–5811. doi: 10.7150/jca.30415

Table 2.

Relationship with clinical characteristics and PET/CT parameters (74 PTCL patients without 6 ALK+ALCL patients)

Characteristics SUVmax P WBSUVmax P WBMTV P WBTLG P
≤9.7
N=29		 >9.7
N=45		 ≤22.2
N=34		 >22.2
N=40		 ≤169.5
N=29		 >169.5
N=45		 ≤746.1
N=26		 >746.1
N=48
Sex(M/F) 16/13 18/27 0.201 18/16 16/24 0.266 16/13 18/27 0.201 14/12 20/28 0.316
Age(≤60/>60) 18/11 24/21 0.459 21/13 21/19 0.423 17/12 25/20 0.795 17/9 25/23 0.270
Stage (I-II/III-IV) 5/24 4/41 0.283 6/28 3/36 0.330 7/22 2/43 0.011 7/19 2/46 0.013
B symptoms (No/Yes) 13/16 16/19 0.425 16/18 13/27 0.201 12/17 17/28 0.757 11/15 18/30 0.686
ECOG PS (<2/≥2) 23/6 35/10 0.876 30/4 28/12 0.058 23/6 35/10 0.876 21/5 37/11 0.713
Extranodal sites (≤1/>1) 24/5 29/16 0.088 29/5 24/16 0.016 24/5 29/16 0.088 21/5 32/16 0.199
BMB (Negtive/Positive) 23/6 35/10 0.876 29/5 29/11 0.183 23/6 35/10 0.876 20/6 38/10 0.823
LDH (≤ULN/>ULN) 14/15 17/28 0.379 19/15 12/28 0.025 15/14 16/29 0.169 13/13 18/30 0.298
HLH (No/Yes) 28/1 42/3 0.942 33/1 37/3 0.727 28/1 42/3 0.943 25/1 42/3 1.00
IPI score (0-2/3-5) 20/9 19/26 0.024 25/9 14/26 0.001 20/9 19/26 0.024 18/8 21/27 0.036
PIT score (0-1/2-4) 19/10 21/24 0.112 24/10 16/24 0.009 20/9 20/25 0.039 18/8 22/26 0.054

Abbreviations: BMB+: positive bone marrow biopsy; ECOG PS: Eastern Cooperative Oncology Group performance status; HLH: hemophagocytic syndrome; IPI: international prognostic index; LDH: lactate dehydrogenase; PIT: the prognostic index for T-cell lymphoma; SUVmax: maximum standard uptake value; ULN: upper limit of normal; WBMTV: whole body metabolic tumor volume; WBSUVmax: whole body SUVmax; WBTLG: whole body total lesion glycolysis